USPTO trademark

GLYPHALLO

AllowedUSPTOWord markClass 5Class 35Class 42

"GLYPHALLO" is a word mark owned by Seaport Therapeutics, Inc., filed at the USPTO on August 14, 2025. It has been allowed and covers classes 5, 35 and 42.

View Seaport Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
GLYPHALLO trademark as filed
As filed with the USPTO
Status
Allowed
Since September 22, 2026
Filed
August 14, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99336892
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns GLYPHALLO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seaport Therapeutics, Inc.

SPTX · Boston, United States

13 trademarks in the portfolioView company

Representative

Nicholas B. Hawkins

Womble Bond Dickinson (US) LLP

Goods and services

What the mark covers

The products and services GLYPHALLO is filed for, grouped by Nice class.

  • Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

  • Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

  • Research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Assigned to examiner

3 earlier steps on the official record.

FAQ

About GLYPHALLO

Who owns the trademark "GLYPHALLO"?

The USPTO trademark "GLYPHALLO" (application 99336892) is owned by Seaport Therapeutics, Inc.

What is the status of "GLYPHALLO"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GLYPHALLO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b0f-fcfb-76ae-9881-9e384cbc3e25
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b0f-fcfb-76ae-9881-9e384cbc3e25",
  "object": "trademark",
  "mark_text": "GLYPHALLO",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99336892",
  "filing_date": "2025-08-14",
  "nice_classes": [
    5,
    35,
    42
  ],
  "owners": [
    {
      "name": "Seaport Therapeutics, Inc.",
      "entity_id": "ent_019f2860-189e-771c-9350-dc01efc037d9"
    }
  ]
}